Study Cites Opdivo Risk; New Indications OK’d for Tecentriq, Keytruda As its lead candidate taxis for takeoff, Kite Pharma is expected this coming week to reveal how soon it will reach altitude—as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results